NL7414241A - Werkwijze ter bereiding van peptiden en van ge- neesmiddelen die deze peptiden bevatten. - Google Patents

Werkwijze ter bereiding van peptiden en van ge- neesmiddelen die deze peptiden bevatten.

Info

Publication number
NL7414241A
NL7414241A NL7414241A NL7414241A NL7414241A NL 7414241 A NL7414241 A NL 7414241A NL 7414241 A NL7414241 A NL 7414241A NL 7414241 A NL7414241 A NL 7414241A NL 7414241 A NL7414241 A NL 7414241A
Authority
NL
Netherlands
Prior art keywords
peptides
preparation
products containing
medicinal products
medicinal
Prior art date
Application number
NL7414241A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4391774A external-priority patent/GB1501855A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7414241A publication Critical patent/NL7414241A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7414241A 1973-11-01 1974-10-31 Werkwijze ter bereiding van peptiden en van ge- neesmiddelen die deze peptiden bevatten. NL7414241A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5081173 1973-11-01
GB4391774A GB1501855A (en) 1974-10-10 1974-10-10 Nona-and decapeptide amides

Publications (1)

Publication Number Publication Date
NL7414241A true NL7414241A (nl) 1975-05-06

Family

ID=26265264

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7414241A NL7414241A (nl) 1973-11-01 1974-10-31 Werkwijze ter bereiding van peptiden en van ge- neesmiddelen die deze peptiden bevatten.

Country Status (10)

Country Link
US (1) US3992365A (enExample)
JP (1) JPS5088069A (enExample)
AU (1) AU497418B2 (enExample)
CA (1) CA1030526A (enExample)
DE (1) DE2451841A1 (enExample)
DK (1) DK568274A (enExample)
FR (1) FR2249677B1 (enExample)
IE (1) IE40257B1 (enExample)
NL (1) NL7414241A (enExample)
SE (1) SE7413710L (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083967A (en) * 1973-11-01 1978-04-11 Burroughs Wellcome Co. Nona- and decapeptides
US4089946A (en) * 1976-06-07 1978-05-16 American Home Products Corporation Claudogenic-interceptive nonapeptides
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4318905A (en) * 1980-06-23 1982-03-09 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
US4705778A (en) * 1985-10-22 1987-11-10 Sri International Orally active LHRH analogs
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
DK2767292T3 (en) 2004-09-17 2016-12-19 Durect Corp RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN109475505A (zh) 2016-07-06 2019-03-15 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1009230A (en) * 1972-09-26 1977-04-26 Daiichi Seiyaku Co. Peptides effecting to the release of sex hormones and a method for preparing the same
US3853834A (en) * 1972-10-19 1974-12-10 Lilly Co Eli 4-alanine lh-rh analog

Also Published As

Publication number Publication date
IE40257L (en) 1975-05-01
JPS5088069A (enExample) 1975-07-15
DK568274A (enExample) 1975-06-23
FR2249677A1 (enExample) 1975-05-30
AU497418B2 (en) 1978-12-14
IE40257B1 (en) 1979-04-25
FR2249677B1 (enExample) 1978-07-28
AU7493074A (en) 1976-05-06
CA1030526A (en) 1978-05-02
DE2451841A1 (de) 1975-05-07
SE7413710L (enExample) 1975-05-02
US3992365A (en) 1976-11-16

Similar Documents

Publication Publication Date Title
NL7411047A (nl) Werkwijze ter bereiding van nieuwe pyrimidinen en van farmaceutische preparaten, die dergelij- ke pyrimidinen bevatten.
NL150680B (nl) Werkwijze ter bereiding van farmaceutische preparaten.
NL7503696A (nl) Werkwijze ter vervaardiging van farmaceutische preparaten, alsmede de aldus gevormde voort- brengselen.
NL174349C (nl) Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.
NL176743C (nl) Verbetering van de werkwijze volgens octrooischrift 161.984 ter bereiding van een farmaceutisch poedervormig inhaleerpreparaat, alsmede een houder, die een dergelijk preparaat bevat.
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
CA957895A (en) High protein product
NL158701B (nl) Werkwijze voor de bereiding van nitroglycerol bevattende mengsels, werkwijze voor de bereiding van farmaceutische preparaten die deze mengsels bevatten en de aldus verkregen gevormde farmaceutische preparaten.
NL167436C (nl) Werkwijze voor de bereiding van 7beta-acylamino- -7alfa-alkoxycefalosporinen en 6beta-acylamino- -6alfa- alkoxypenicillinen, alsmede gevormd genees- middel.
NL7514255A (nl) Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten.
GB1402930A (en) 3-aroyl-azacycloalkenes process for their manufacture and pharmaceutical preparations containing them
NL7603972A (nl) Werkwijze ter bereiding van geneesmiddelen die een polypeptide bevatten.
NL7506011A (nl) Werkwijze ter bereiding van nieuwe derivaten van benzodiazepinen en van farmaceutische preparaten, die deze nieuwe derivaten bevatten.
AU2207570A (en) Pyridinesulfonic acids, process for their manufacture and pharmaceutical preparations containing them
NL7509482A (nl) Werkwijze ter bereiding van kaneelzuuramide- derivaten en van therapeutische preparaten die deze stoffen bevatten.
NL185841C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van voor toepassing daarbij geschikte 5-mercaptopyridoxinederivaten.
NL164037C (nl) Werkwijze ter bereiding van 1,4-dithiino- -Ÿ2,3-cŸpyrrool-derivaten en van farmaceutische preparaten die deze derivaten bevatten.
NL7414751A (nl) Werkwijze voor de bereiding van bisdiorgano- oerthofosfaten alsmede de toepassing daarvan.
AU7194974A (en) Pharmaceutical product
NL175063C (nl) Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
CA1022099A (en) Process for the preparation of technical white oils and medicinal oils
CA964189A (en) Medicinal solution and process for preparing it
NL162902C (nl) Werkwijze voor de bereiding van oxaprostaglandien- -analoga en voor de bereiding van farmaceutische prepa- raten die ze bevatten.
NL176171C (nl) Werkwijze voor de bereiding van anti-adrenerge verbindingen en voor de bereiding van preparaten die ze bevatten.
ZA737959B (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids,process for their manufacture and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
BV The patent application has lapsed